SSB TPP20_Performance Measures_Part_B_Supporting_Statement_2023_0990_0438 reinst

Supporting Statement B for Reinstatement of TPP2020 Teen Pregnancy Prevention Performance Measures Collection, OMB Control No. 0990-0438

September 2023

Office of Population Affairs

U.S. Department of Health and Human Services

1101 Wootton Parkway, Suite 200

Rockville, MD 20852

Tara Rice, tara.rice@hhs.gov, 240-453-8123

The Office Population Affairs (OPA), (formerly the Office of Adolescent Health (OAH), which merged into OPA, effective June 2019) is requesting approval for a one-year reinstatement without change of the performance measures for the Teen Pregnancy Prevention (TPP) Program grantees funded in FY2020.

The TPP Program was initiated in FY 2010 as one of six major evidence-based policy initiatives across the Federal government. OAH supports two types of grants through the TPP program (1) projects that replicate evidence-based TPP program models that have been shown to be effective through rigorous evaluation, referred to as Tier 1 and (2) research and demonstration projects that develop and test additional models and innovative strategies to prevent teen pregnancy, referred to as Tier 2. Funding for the TPP Program is authorized under the authority of Division A, Title II of the Further Consolidated Appropriations Act, 2020 (Public Law No. 116-94).). The Act provides $100 million in FY 2020 for making competitive awards to public and private entities to fund programs that reduce teen pregnancy. OPA anticipates TPP2020 grantees will continue during a no-cost extension (NCE) period of up to one year from July 2023 through June 2024, and requests a one year extension without change of the TPP2020 performance measures information clearance request so that grantees may continue data reporting during the NCE period.

B. Collection of Information Employing Statistical Methods

1. Respondent Universe and Sampling Methods

We estimate up to 96 TPP2020 grantees will be on a no-cost extension during FY 2023. All of these grantees will be reporting data; there will be no sampling of respondents. A couple of items are specific to a particular tier, such as the Tier 1 Supportive Services and Tier 2 Innovative Network projects items; the participant-level items are not relevant to the Tier 2 Innovative Network participants. For observed quality and fidelity measures, Tier 1 and Tier 2 Phase II grantees will report on a sample of at least 10% of program sessions.

2. Procedures for the Collection of Information

Most of the program-level measures (pertaining to participant reach, dosage, and fidelity) collected by grantees and their sub-awardees (or implementing organizations, who potentially could be partners that are not funded directly through the grants) will be collected by aggregating data obtained from the staff implementing the program. The grantee-level measures (such as number of partners, training, dissemination, sustainability) will be tracked and summarized from the grantees’ or sub-awardees’ administrative records. All measures will be entered into the cloud-based database.

3. Methods to Maximize Response Rates and Deal with Non-response

Because completion of performance measures has been a funding requirement for the TPP cooperative agreements awarded since 2010, we have had nearly a 100% grantee response rate for the cohorts of TPP grantees. This requirement was stipulated in each of the three funding opportunity announcements for the FY 2020 awards. All grantees were trained and given ongoing technical assistance in the web based data collection procedures to facilitate their reporting.

4. Tests of Procedures or Methods to be Undertaken

These measures have been reported successfully over the past 10+ years.

5. Individuals Consulted on Statistical Aspects and Individuals Collecting and/or Analyzing Data

The agency officials responsible for receiving and approving contract deliverables are:

Tara Rice

240-453-8123

Tara.Rice@hhs.gov

Office of Population Affairs/HHS
1101 Wootton Parkway, Suite 200
Rockville, MD 20852

Amy Farb
240-453-2836
Amy.Farb@hhs.gov

Office of Population Affairs/HHS
1101 Wootton Parkway, Suite 200
Rockville, MD 20852

The persons who designed the data collection are:

Tara Rice

240-453-8123

Tara.Rice@hhs.gov

Office of Population Affairs/HHS

1101 Wootton Parkway, Suite 200
Rockville, MD 20852

Nicole Bennett

Nicole.Bennett@hhs.gov

Office of Population Affairs/HHS

1101 Wootton Parkway, Suite 200
Rockville, MD 20852

Jaclyn Ruiz

Jaclyn.Ruiz@hhs.gov

Office of Population Affairs/HHS

1101 Wootton Parkway, Suite 200
Rockville, MD 20852

Amy Margolis

Amy.Margolis@hhs.gov

Office of Population Affairs/HHS
1101 Wootton Parkway, Suite 200
Rockville, MD 20852

Barri Burrus

919-597-5109

barri@rti.org

RTI International

3040 E. Cornwallis

Research Triangle Park, NC 27709

Eric Peele

(919) 316-3898

epeele@rti.org

RTI International

3040 E. Cornwallis Drive

Research Triangle Park, NC 27709

Ellen Wilson

919-316-3337

ewilson@rti.org

RTI International

3040 E. Cornwallis

Research Triangle Park, NC 27709

Ina Wallace

919-541-6967

wallace@rti.org

RTI International

3040 E. Cornwallis

Research Triangle Park, NC 27709